Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Poland joined the Initiative Valve for Life in August 2015 as pilot country. It was selected on the basis of the infrastructure in place and the disparity of challenges faced in the access to transcatheter heart valve therapies for patients.
Back in 2015
These challenges were aken into consideration while conducting the Initiative in Poland.
Poland has managed to conduct a very strong TAVI public campaign. First of all, it has performed an assessment of public awareness of TAVI and a new treatment for patients with severe aortic stenosis not suitable for cardiac surgery. VFL Poland has also created a dedicated website and a special television campaign with video spots. It has run dedicated pages on the Facebook.
Valve for Life Poland Country Champions, Prof Dariusz Dudek and Prof Adam Witkowski participated in different interviews on TAVI and programs in newspapers, radio and TV. The topic of TAVI and a new treatment for patients with severe aortic stenosis not suitable for cardiac surgery was addressed also during the local symposia for cardiologists, interventionalists and family doctors as well as during the THT Poland Congress.
In general, the campaign stats grouping television, radio, press, interviews, social media reached out to 6+ million people.
Access to the campaign
VFL Poland has also focused its attention on reaching the governmental officials aiming to increase their awareness in situation around TAVI in Poland and ensuring their support. In October 2015 a meeting with a Minister of Health of Poland was organized which resulted in a number of positive changes. In particular, funding was successfully secured for the refund of 100 additional TAVI for 2016.
The aim is to raise the number of relevant procedures over the next five years to about 2 000 procedures annually.
What was achieved?
Country Champions: Profs Dariusz Dudek and Adam WitkowskiLast update: March 2019
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.